AJ7-12808-35659
4 vaccinations
3 coded responses
23 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 481 / MI
- Registered
- 2021-04-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-19
Dose 1 — Moderna
-
2021-04-16
Registered in v-safe
-
2021-04-16
Dose 2 — Moderna
- 2021-04-16
-
2021-04-17
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness, Eye irritation — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Nausea, Vomiting · Be unable to do your normal daily activitiesFree text: Burning eyes; dizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-18
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-19
- 2021-04-20
-
2021-04-21
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-04-22
- 2021-04-23
- 2021-05-01
- 2021-05-07
- 2021-05-14
- 2021-05-23
- 2021-05-30
- 2021-07-17
- 2021-10-15
-
2021-11-05
Dose 3 — Moderna
-
2022-04-05
Dose 4 — Moderna
- 2022-04-16
- 2022-05-01
- 2022-05-05
- 2022-05-12
-
2022-05-17
Survey response — day 42, dose 4MedDRA: COVID-19, Cough, Headache, Nasal congestion — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Cough, stuffy nose, headache, COVIDMedDRA releases: 2024-11 · check-in free text available
-
2022-05-17
Report sent to call center — day 42, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-05-18
Call successfulParticipant prefers to complete VAERS report online
-
2022-07-05
Survey response — 3 months, dose 4MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: CovidMedDRA releases: 2024-11 · check-in free text available
-
2022-07-05
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-07-06
- 2022-07-06
-
2022-07-06
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-10-04
- 2023-04-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-19 | Moderna | |
| 2 | 2021-04-16 | Moderna | |
| 3 | 2021-11-05 | Moderna | No |
| 4 | 2022-04-05 | Moderna | No |
Call center
2 call center cases
2 successful
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Burning eyes; dizziness
Release 11 — day 42, dose 4
Symptoms: Cough, stuffy nose, headache, COVID
Release 12 — 3 months, dose 4
Symptoms: Covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Eye irritation | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release